What is Insmed's pre-tax income (foreign)?

Insmed (INSM) reported pre-tax income (foreign) of -$38.31M in Q4 2025.

How has Insmed's pre-tax income (foreign) changed year-over-year?

Insmed's pre-tax income (foreign) decreased by 60.4% year-over-year, from -$23.88M to -$38.31M.

What is the long-term trend for Insmed's pre-tax income (foreign)?

Over 4 years (2021 to 2025), Insmed's pre-tax income (foreign) has grown at a 15.0% compound annual growth rate (CAGR), from -$87.57M to -$153.26M.

What does pre-tax income (foreign) mean?

Pre-tax profit earned specifically from international business operations.

Discontinued — last reported Q4 '25

Income Before Tax

Pre-Tax Income (Foreign)

Insmed Pre-Tax Income (Foreign) remained flat by 0.0% to -$38.31M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 60.4%, from -$23.88M to -$38.31M. Over 4 years (FY 2021 to FY 2025), Pre-Tax Income (Foreign) shows a downward trend with a 15.0% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.

Analysis

StatementIncome Statement

SectionIncome Before Tax

CategoryProfitability

SignalHigher is better

VolatilityModerate

First reportedQ1 2015

Last reportedQ4 2025

How to read this metric

An increase indicates successful global expansion or favorable international market conditions.

Detailed definition

The portion of pre-tax earnings generated from operations outside the company's home country. This highlights the compan...

Peer comparison

Standard geographic breakdown for multinational firms; highly dependent on global footprint.

Metric ID: msft_income_before_tax_foreign

Historical Data

5 years

	FY'21	FY'22	FY'23	FY'24	FY'25
Value	-$87.57M	-$73.89M	-$80.83M	-$95.53M	-$153.26M
YoY Change	—	+15.6%	-9.4%	-18.2%	-60.4%

Range-$153.26M – -$73.89M

CAGR+15.0%

Avg YoY Growth-18.1%

Median YoY Growth-13.8%

Current Streak3 years decline

Pre-Tax Income (Foreign) at Other Companies

Vertex PharmaceuticalsVRTX View metric

Frequently Asked Questions

What is Insmed's pre-tax income (foreign)?: Insmed (INSM) reported pre-tax income (foreign) of -$38.31M in Q4 2025.
How has Insmed's pre-tax income (foreign) changed year-over-year?: Insmed's pre-tax income (foreign) decreased by 60.4% year-over-year, from -$23.88M to -$38.31M.
What is the long-term trend for Insmed's pre-tax income (foreign)?: Over 4 years (2021 to 2025), Insmed's pre-tax income (foreign) has grown at a 15.0% compound annual growth rate (CAGR), from -$87.57M to -$153.26M.
What does pre-tax income (foreign) mean?: Pre-tax profit earned specifically from international business operations.